ExodusPoint Capital Management’s Bicycle Therapeutics BCYC Stock Holding History

ExodusPoint Capital Management’s Portfolio BCYC Stock Details BCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-111,973	Closed	-$2.86M	–	1703
2023 Q2	$2.86M	Sell	111,973 -10,808	-9%	-$251K	0.02%	665
2023 Q1	$2.61M	Buy	122,781 +17,915	+17%	+$449K	0.02%	775
2022 Q4	$3.1M	Buy	104,866 +26,184	+33%	+$702K	0.05%	490
2022 Q3	$1.83M	Sell	78,682 -103,443	-57%	-$2.46M	0.02%	834
2022 Q2	$3.06M	Buy	+182,125	New	+$3.84M	0.04%	603

Other funds holding BCYC

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

TCM

Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

ExodusPoint Capital Management's BCYC Position: Q3 2023 in Review

ExodusPoint Capital Management sold out of Bicycle Therapeutics (BCYC) in Q3 2023, closing a stake of 111,973 shares — an estimated $2.86M sold.

ExodusPoint Capital Management first reported a position in BCYC in Q2 2022 and held it in 5 quarters. The position peaked at $3.1M in Q4 2022. 101 funds tracked by Wall St. Rank hold BCYC as of Q3 2023.

ExodusPoint Capital Management reported no remaining Bicycle Therapeutics position as of Q3 2023 after selling out during the quarter.
ExodusPoint Capital Management sold 111,973 Bicycle Therapeutics shares in Q3 2023, an estimated $2.86M.
ExodusPoint Capital Management first reported a position in Bicycle Therapeutics in Q2 2022 and held it in 5 quarters.
ExodusPoint Capital Management's Bicycle Therapeutics position peaked at $3.1M in Q4 2022.
101 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2023.

Based on ExodusPoint Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.